VOYA Investment Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.2M Buy
156,169
+108,403
+227% +$15.8M 0.03% 423
2026
Q1
$4.65M Sell
47,766
-12,471
-21% -$1.26M ﹤0.01% 858
2025
Q4
$4.8M Buy
60,237
+12,703
+27% +$833K ﹤0.01% 880
2025
Q3
$2.22M Buy
47,534
+921
+2% +$36.1K ﹤0.01% 1190
2025
Q2
$1.71M Sell
46,613
-272,878
-85% -$10.5M ﹤0.01% 1366
2025
Q1
$11.3M Buy
319,491
+3,463
+1% +$141K 0.01% 705
2024
Q4
$13.8M Buy
316,028
+3,901
+1% +$197K 0.01% 652
2024
Q3
$14.2M Buy
312,127
+40,930
+15% +$1.78M 0.01% 660
2024
Q2
$10.5M Sell
271,197
-20,268
-7% -$758K 0.01% 740
2024
Q1
$9.39M Buy
291,465
+108,284
+59% +$3.21M 0.01% 777
2023
Q4
$5.25M Buy
183,181
+142,743
+353% +$3.43M 0.01% 982
2023
Q3
$1.12M Buy
40,438
+319
+0.8% +$9.46K ﹤0.01% 1572
2023
Q2
$1.07M Buy
40,119
+6,847
+21% +$168K ﹤0.01% 1630
2023
Q1
$721K Buy
33,272
+4,729
+17% +$116K ﹤0.01% 1835
2022
Q4
$680K Buy
28,543
+370
+1% +$7.87K ﹤0.01% 1853
2022
Q3
$556K Buy
28,173
+4,760
+20% +$105K ﹤0.01% 1966
2022
Q2
$456K Hold
23,413
﹤0.01% 1896
2022
Q1
$597K Hold
23,413
﹤0.01% 1799
2021
Q4
$589K Buy
23,413
+87
+0.4% +$2.45K ﹤0.01% 1906
2021
Q3
$642K Hold
23,326
﹤0.01% 1893
2021
Q2
$740K Buy
23,326
+4,853
+26% +$169K ﹤0.01% 1846
2021
Q1
$848K Buy
18,473
+1,676
+10% +$75.2K ﹤0.01% 1700
2020
Q4
$665K Buy
16,797
+4,018
+31% +$159K ﹤0.01% 1748
2020
Q3
$445K Buy
+12,779
New +$354K ﹤0.01% 1740

Other funds holding RVMD

VOYA Investment Management's RVMD Position: Q2 2026 in Review

VOYA Investment Management increased its Revolution Medicines (RVMD) stake by 227% in Q2 2026, buying an estimated $15.8M and bringing the position to 156,169 shares worth $29.2M. The position accounts for 0.03% of the portfolio, ranked #423.

VOYA Investment Management first reported a position in RVMD in Q3 2020 and has held it in 24 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • VOYA Investment Management held 156,169 shares of Revolution Medicines worth $29.2M as of Q2 2026.
  • VOYA Investment Management bought 108,403 Revolution Medicines shares in Q2 2026, an estimated $15.8M.
  • Revolution Medicines made up 0.03% of VOYA Investment Management's portfolio in Q2 2026, its #423 holding.
  • VOYA Investment Management first reported a position in Revolution Medicines in Q3 2020 and has held it in 24 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.